Furthermore, no significant differences in serum PSA levels were found between BPH and prostate adenocarcinoma, and no correlations were observed between PSA levels and Gleason grade within the prostate cancer group, confirming the limited specificity of PSA and its inconsistent relationship with tumor aggressiveness. The gene discussed is KLK3; the disease is neoplasm.